2,7-二氨基辛二酸 | 84211-42-7

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 中文名称: 2,7-二氨基辛二酸
• 英文名称: meso-α,α'-Diamino-suberinsaeure
• 英文别名: 2,7-diaminooctanedioic acid；2,7-bis(azaniumyl)octanedioate
• CAS: 84211-42-7
• 化学式: C₈H₁₆N₂O₄
• mdl: MFCD00673800
• 分子量: 204.226
• InChiKey: YQZHANAPVDIEHA-UHFFFAOYSA-N

物化性质

• 熔点：
  >360 °C
• 沸点：
  437.3±45.0 °C(Predicted)
• 密度：
  1.292±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  -5.5
• 重原子数：
  14
• 可旋转键数：
  7
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.75
• 拓扑面积：
  127
• 氢给体数：
  4
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  2,7-二氨基辛二酸 生成 1,6-己二胺
  参考文献：
  名称：

  Neuberg; Neimann, Hoppe-Seyler's Zeitschrift fur Physiologische Chemie, 1905, vol. 45, p. 120

  摘要：

  DOI：
• 作为产物：
  描述：

  2,7-bis-hydroxyimino-octanedioic acid diethyl ester 在 盐酸 、 tin 作用下， 生成 2,7-二氨基辛二酸
  参考文献：
  名称：

  The irradiation history of the Ghubara (L5) regolith breccia

  摘要：

  Abstract— We measured cosmic‐ray products—noble gases, radionuclides, thermoluminescence, and nuclear tracks—and trace element contents and mineralogy of samples of three orthogonal and mutually intersecting cores (41–46 cm long) of a 101.6 kg Ghubara individual (1958,805) at The Natural History Museum, London. The xenoliths, like the host, have high concentrations of trapped solar gases and are heavily shocked. While contents of noble gases and degree of shock‐loading in this individual and three others differ somewhat, the data indicate that Ghubara is a two‐generation regolith breccia. Contents of cosmogenic 26Al and 10Be and low track densities indicate that the Ghubara individuals were located more than 15 cm below the surface of an 85 cm meteoroid. Because of its large size, Ghubara's cosmic‐ray exposure age is poorly defined to be 15–20 Ma from cosmogenic nuclides. Ghubara's terrestrial age, based on 14C data, is 2–3 ka. Not only is Ghubara the first known case of a two‐generation regolith breccia on the macroscale, it also has a complicated thermal and irradiation history.

  DOI：

  10.1111/j.1945-5100.2002.tb00819.x

文献信息

• [EN] NUCLEIC ACID BINDING COMPOUNDS, METHODS OF MAKING, AND USE THEREOF<br/>[FR] COMPOSÉS DE LIAISON D'ACIDE NUCLÉIQUE, PROCÉDÉS DE FABRICATION, ET UTILISATION DE CEUX-CI
  申请人：UNIV ROCHESTER

  公开号：WO2012092367A1

  公开（公告）日：2012-07-05

  The present invention relates to oligomer compounds, including dimers and trimers, formed by a disulfide, sulfinyl thio, olefin or hydrocarbon bond, or a hydrazone exchange bond between two or more monomers. Methods of making the monomers and the oligomers is also disclosed. Use of the compounds for inhibiting the activity of target RNA molecules, particularly those having a secondary structure that include a stem or stem-loop formation. Dimer compounds capable of inhibiting the activity of an HIV-1 RNA frameshifting stem-loop and a (CUG)n expanded repeat stem- loop are disclosed, as are methods of treating diseases associated with these target RNA molecules.

  本发明涉及由二硫化物、亚硫醚硫、烯烃或碳氢键，或两个或更多单体之间的缩醛交换键形成的寡聚物化合物，包括二聚体和三聚体。还公开了制备单体和寡聚物的方法。利用这些化合物抑制靶RNA分子的活性，特别是那些具有包括茎或茎环形成的二级结构的RNA分子的活性。公开了能够抑制HIV-1 RNA移码茎环和(CUG)n扩展重复茎环活性的二聚体化合物，以及治疗与这些靶RNA分子相关的疾病的方法。
• Conotoxin analogues and methods for synthesis of intramolecular dicarba bridge-containing peptides
  申请人：Robinson Andrea

  公开号：US20070197429A1

  公开（公告）日：2007-08-23

  According to the present invention, there is provided a range of new conotoxin derivatives and methods for synthesizing these analogues and other intramolecular dicarba bridge-containing peptides, including dicarba-disulfide bridge-containing peptides.

  根据本发明，提供了一系列新的芋螺毒素衍生物以及合成这些类似物和其他含内分子二碳桥肽的方法，包括含二碳-二硫桥肽。
• Inhibitors of hepatitis C virus NS3 protease
  申请人：——

  公开号：US20020065248A1

  公开（公告）日：2002-05-30

  The present invention relates to compounds of Formula (I): 1 wherein A 1 is methylene, ethylene or propylene group and A 2 is N or CR 5 , or stereoisomeric forms, stereoisomeric mixtures, or pharmaceutically acceptable salt forms thereof, which are useful as inhibitors of HCV NS3 protease, and to pharmaceutical compositions and diagnostic kits comprising the same, and methods of using the same for treating viral infection or as an assay standard or reagent.

  本发明涉及化合物的结构公式（I）：其中A1为亚甲基、乙烯基或丙烯基，A2为N或CR5，或其立体异构体形式、立体异构体混合物或药用盐形式，用作HCV NS3蛋白酶的抑制剂，以及包含相同化合物的药物组合物和诊断试剂盒，以及用于治疗病毒感染或作为测定标准或试剂的方法。
• [EN] ADRENOMEDULLIN-ANALOGUES FOR LONG-TERM STABILIZATION AND THEIR USE<br/>[FR] ANALOGUES D'ADRÉNOMÉDULLINE POUR STABILISATION À LONG TERME ET LEUR UTILISATION
  申请人：BAYER AG

  公开号：WO2020254197A1

  公开（公告）日：2020-12-24

  The invention relates to stabilized Adrenomedullin derivatives and use thereof. In particular, the invention relates to novel, biologically active, stabilized Adrenomedullin (ADM) compounds. The invention further relates to the compounds for use in a method for the treatment and/or prevention of diseases, especially of cardiovascular, edematous and/or inflammatory disorders, and to medicaments comprising the compounds for treatment and/or prevention of cardiovascular, edematous and/or inflammatory disorders.

  该发明涉及稳定的肾上腺髓质素衍生物及其用途。具体而言，该发明涉及新型、具有生物活性的稳定肾上腺髓质素（ADM）化合物。该发明进一步涉及用于治疗和/或预防疾病的方法中的化合物，特别是心血管、水肿和/或炎症性疾病，以及包含该化合物的药物，用于治疗和/或预防心血管、水肿和/或炎症性疾病。
• Compounds for Control of Appetite
  申请人：Balasubramaniam Ambikaipakan

  公开号：US20080221038A1

  公开（公告）日：2008-09-11

  This invention relates generally to peptides including tripeptides and to methods for pharmaceutical treatment of mammals using such tripeptides and analogs thereof. More specifically, the invention is directed to neuropeptide Y (“NPY”) receptor antagonists and agonists including O-glycosylated tripeptides, i.e. O-glycopeptides, and extended tripeptides, and their analogs, as well as to PYY analogs, to pharmaceutical compositions containing such tripeptides and PYY analogs, and to methods of treatment of mammals using such tripeptides and PYY analogs. In addition, the invention relates to methods of treatment of mammals using such tripeptides and PYY analogs for control of appetite, blood pressure, cardiovascular response, libido, and circadian rhythm.

  这项发明涉及一般的肽包括三肽以及使用这些三肽及其类似物对哺乳动物进行药物治疗的方法。更具体地，该发明涉及神经肽Y（“NPY”）受体拮抗剂和激动剂，包括O-糖基化三肽，即O-糖肽，以及扩展三肽及其类似物，以及PYY类似物，包括含有这些三肽和PYY类似物的药物组合物，以及使用这些三肽和PYY类似物对哺乳动物进行治疗的方法。此外，该发明涉及使用这些三肽和PYY类似物进行治疗的方法，用于控制食欲、血压、心血管反应、性欲和昼夜节律。